Showing results (211-220 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effectsA Faradji, A Bohbot, M Schmitt-Goguel, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2006
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccinesDeepak P Assudani, Roger B V Horton, Morgan G Mathieu, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2006
Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivoQingfen Li, Li Li, Wenfang Shi, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic studyR D Blumenthal, I Fand, R M Sharkey, et al.Cancer Immunology, Immunotherapy : CII|March 15, 2006
Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28Jun-Feng Han, Ting-Ting Zhao, Hong-Li Liu, et al.Cancer Immunology, Immunotherapy : CII|February 24, 2006
CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cellsAndrew Lodge, Ping Yu, Michael B Nicholl, et al.Cancer Immunology, Immunotherapy : CII|February 24, 2006
Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocationYohei Kida, Sachiyo Tsuji-Kawahara, Valentina Ostapenko, et al.Cancer Immunology, Immunotherapy : CII|February 24, 2006
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignanciesIgnacio Azinovic, Gerald L DeNardo, Kathleen R Lamborn, et al.Cancer Immunology, Immunotherapy : CII|December 1, 2007
Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic diseaseTao Gu, Mehmet O Kilinc, Nejat K EgilmezCancer Immunology, Immunotherapy : CII|December 7, 2007
Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapyAlison Merrick, Rosa Maria Diaz, Dearbhaile O'Donnell, et al.Pageof 650